# N4 Pharma MTAs demonstrate commercial interest (Analyst Interview)

- Link: https://www.directorstalkinterviews.com/n4-pharma-mtas-demonstrate-commercial-interest-analyst-interview/4121010561
- Published: 2021-07-19T10:41:17+01:00
- Author: Giles

**N4 Pharma plc** (LON:N4P) is the topic of conversation when SP Angel Analyst Vadim
Alexandre joins DirectorsTalk. Vadim talks us through the main points of their latest
research note, explains what the current vaccine landscape means for the company,
why someone might want to invest in the company and what can be expected from N4
over the coming months.

N4 Pharma, are a specialist pharmaceutical company developing a novel silica nanoparticle
delivery system for vaccines and therapeutics for licensing to pharmaceutical and
biotech partners. This nanoparticle has the potential to help commercialise cancer
immunotherapy drugs and improve the effectiveness of viral vaccines.

Share on:
